Literature DB >> 690038

Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination.

B A Lauer, L B Reller, G P Schröter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 690038     DOI： 10.1093/jac/4.4.375

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

Review 1.  Combination antifungal therapy.

Authors:  Melissa D Johnson; Conan MacDougall; Luis Ostrosky-Zeichner; John R Perfect; John H Rex
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

Review 2.  Antifungal combination therapy: clinical potential.

Authors:  John W Baddley; Peter G Pappas
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.

Authors:  C E Hughes; C Harris; J A Moody; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

Review 4.  Antifungal agents used in systemic mycoses. Activity and therapeutic use.

Authors:  J R Graybill; P C Craven
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

5.  Aspergillus granuloma of the trigeminal ganglion.

Authors:  C M Wiles; R S Kocen; L Symon; F Scaravilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-05       Impact factor: 10.154

Review 6.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

7.  In vitro interactions between amphotericin B, itraconazole, and flucytosine against 21 clinical Aspergillus isolates determined by two drug interaction models.

Authors:  D T A Te Dorsthorst; P E Verweij; J F G M Meis; N C Punt; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

8.  Inhibition of nucleotide biosynthesis potentiates the antifungal activity of amphotericin B.

Authors:  Dithi Banerjee; Lauren Burkard; John C Panepinto
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.